This is the authors' abstract. We don't add key points for this paper.
Type 2 diabetes mellitus (T2DM) is a major health problem in worldwide and uncoupling protein-2 (UCP2) that have a role in the regulation of insulin secretion and emergence of diabetes mellitus. In this study we have investigate whether an association between UCP2 866 G/A polymorphism and T2DM. In this study we have collected peripheral blood samples from 50 type 2 diabetes mellitus patients and 50 healhty control individuals. Genomic DNA was isolated from blood samples and UCP2 866 G/A polymorphism was investigated by polymerase chain reaction restriction fragment lenght polymorphism assay (PCR-RFLP). In our results we have not observed any statistically significant association between UCP2 866 G/A polymorphism and risk of T2DM.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Gözel et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: